Integrating Lutetium-177-PSMA-617: Sequencing, Combinations, and Safety in Taxane-Naïve mCRPC - Michael Morris
Integrating Lutetium-177-PSMA-617: Sequencing, Combinations, and S…
3 months ago
urotoday.com
Access to Cabazitaxel vs. 177Lu-PSMA-617 in mCRPC: Challenges and Solutions for Rural and Community-Based Settings
Access to Cabazitaxel vs. 177Lu-PSMA-617 in mCRPC: Challenges …
4 months ago
vumedi.com
Potential Role of Lu-PSMA-617 in mCRPC | OncLive
Potential Role of Lu-PSMA-617 in mCRPC | OncLive
1 week ago
onclive.com
Dr. Gafita on Sequencing 177Lu-PSMA-617 in mCRPC | OncLive
Dr. Gafita on Sequencing 177Lu-PSMA-617 in mCRPC | OncLive
3 weeks ago
onclive.com
ESMO 2024 Insights: STAMPEDE2 Comparison P - Upfront Accelerated 177Lu-PSMA-617 in mHSPC
ESMO 2024 Insights: STAMPEDE2 Comparison P - Upfront Accelerat…
85 viewsSep 25, 2024
vumedi.com
The VISION Study of 177Lu-PSMA-617 in mCRPC | OncLive
The VISION Study of 177Lu-PSMA-617 in mCRPC | OncLive
3 weeks ago
onclive.com
Efficacy and Toxicity of 177Lu-PSMA-617 for mCRPC: Results From the U.S. Expanded Access Program & Comparison With Phase 3 VISION Data
Efficacy and Toxicity of 177Lu-PSMA-617 for mCRPC: Results Fr…
108 viewsNov 20, 2024
vumedi.com
ESMO 2025 Insights: 177Lu-PSMA-617 With ADT ARPI Improves rPF…
24 views3 months ago
vumedi.com
This VISION Trial Secondary Analysis: 177Lu-PSMA-617 With C…
114 views11 months ago
vumedi.com
ASCO® GU 2025 Insights: Efficacy of 177Lu-PSMA-617 /- ARPIs for th…
135 viewsMar 6, 2025
vumedi.com
ASCO® GU 2025 Insights: mCRPC Survival Outcomes With 177Lu-PS…
147 viewsFeb 25, 2025
vumedi.com
ESMO 2025 Insights: Lutetium-177 PSMA-617 vs. Docetaxel in mCRP…
180 views3 months ago
vumedi.com
ASCO® GU 2024 Insights: "Impact of Race on Outcomes to 177Lu-PS…
32 viewsFeb 20, 2024
vumedi.com
ASCO® 2025 Insights: Robust Characterization of Response and …
38 views8 months ago
vumedi.com
ASCO® 2025 Insights: Liquid Biopsy Approaches to Detect PSMA and 1…
99 views8 months ago
vumedi.com
ESMO 2025 Insights: Phase 3 PSMAddition Trial of [177Lu]Lu-P…
144 views4 months ago
vumedi.com
Treatment Sequencing in mCRPC: Evidence From VISION, TheraP, a…
154 views9 months ago
vumedi.com
Clinical Considerations Related to Lutetium 177– PSMA-617 Treatme…
Aug 2, 2022
curetoday.com
Pilot experience of [ 161 Tb]Tb-PSMA-617 RLT in mCRPC patient…
5 months ago
linkedin.com
What is the Role of 177Lu-PSMA-617 in Metastatic CRPC? | OncLive
1 week ago
onclive.com
Dr. Gafita on Prognostic Models for Treatment With 177Lu-PSMA-617 i…
Aug 5, 2020
onclive.com
Dr. Morris on Logistical Challenges of Using 177Lu-PSMA-617 in Prost…
Jan 11, 2022
onclive.com
Dr. Sartor on Outcomes With 177Lu-PSMA-617 After Radium-223 in m…
Jun 18, 2020
onclive.com
Dr. Morris on the Efficacy of 177Lu-PSMA-617 Plus Best SOC in mCR…
Aug 19, 2021
onclive.com
FDA Approval of 177Lu-PSMA-617 for Taxane-Naive mCRPC - Oliver …
11 months ago
urotoday.com
6:17
177Lu-PSMA-617 in metastatic castration-resistant prostate canc…
17 views4 weeks ago
YouTubeecancer
12:38
Latest news from ProstateWarriors.com 23 Novemb…
3 months ago
YouTubeProstateWarriors
1:39
177Lu-PSMA-617 after sipuleucel-T in mCRPC: PRECISION analysis
1 views6 days ago
YouTubeVJOncology
Can PSMA PET Parameters Help Predict Toxicity and Outcomes in …
1 month ago
diagnosticimaging.com
Efficacy & Toxicity of 177Lu-PSMA-617 for mCRPC in a Real-World Se…
Nov 7, 2024
vumedi.com
See more videos
Static thumbnail place holder